‘I Really Could Not Refuse’: Pharmascience CEO Arès Reflects On First Six Months

Canadian Generics Manufacturer Has Ambitions To Double Sales By End Of Decade

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.